{
    "name": "Al-Tuwairqi2020 - Dynamics of cancer radiovirotherapy - Phase II treatment",
    "description": "<notes xmlns=\"http://www.sbml.org/sbml/level2/version4\">      <body xmlns=\"http://www.w3.org/1999/xhtml\">        <pre>This ordinary differential equation model of cancer radiovirotherapy dynamics is described in the publication:Salma M. Al-Tuwairqi, Najwa O. Al-Johani, Eman A. Simbawa,\"Modeling dynamics of cancer radiovirotherapy\",Journal of Theoretical Biology, Volume 506, 2020, 110405, ISSN 0022-5193,DOI: 10.1016/j.jtbi.2020.110405.Comment:This model is represented by the equations in system (14) of the publication manuscript and describes the cancer-virus interactions for the Phase II radiovirotherapy treatment.Abstract:Advances in genetic engineering have paved the way for a new therapy for cancer, which is called virotherapy. This treatment uses genetically engineered viruses which selectively infect, replicate in, and destroy cancer cells without damaging normal cells. Furthermore, current research and clinical trials have indicated that these viruses can be delivered as single agents or in combination with other therapies. In this paper, we propose systems of ordinary differential equations for modeling the dynamics of aggressive tumor growth under radiovirotherapy treatment. We divide the treatment period into two phases; consequently, we present two mathematical models. First, we formulate the virotherapy model as Phase I of the treatment. Then we extend the model to include radiotherapy in combination with virotherapy as Phase II of the treatment. Comprehensive qualitative analyses of both models are conducted. Furthermore, numerical experiments are performed in order to support the analytical results. An analysis of the parameters is also carried out to investigate their effects on the outcome of the treatment. Overall, the analytical results reveal that radiovirotherapy is more effective than, and a good alternative to, virotherapy, as it is capable of eradicating tumors completely.</pre>      </body>    </notes>",
    "format": {
        "name": "SBML",
        "identifier": "SBML",
        "version": "L2V4"
    },
    "publication": {
        "type": "PubMed ID",
        "accession": "32738266",
        "journal": "Journal of theoretical biology",
        "title": "Modeling dynamics of cancer radiovirotherapy.",
        "affiliation": "Mathematics department, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: saltuwairqi@kau.edu.sa.",
        "synopsis": "Advances in genetic engineering have paved the way for a new therapy for cancer, which is called virotherapy. This treatment uses genetically engineered viruses which selectively infect, replicate in, and destroy cancer cells without damaging normal cells. Furthermore, current research and clinical trials have indicated that these viruses can be delivered as single agents or in combination with other therapies. In this paper, we propose systems of ordinary differential equations for modeling the dynamics of aggressive tumor growth under radiovirotherapy treatment. We divide the treatment period into two phases; consequently, we present two mathematical models. First, we formulate the virotherapy model as Phase I of the treatment. Then we extend the model to include radiotherapy in combination with virotherapy as Phase II of the treatment. Comprehensive qualitative analyses of both models are conducted. Furthermore, numerical experiments are performed in order to support the analytical results. An analysis of the parameters is also carried out to investigate their effects on the outcome of the treatment. Overall, the analytical results reveal that radiovirotherapy is more effective than, and a good alternative to, virotherapy, as it is capable of eradicating tumors completely.",
        "year": 2020,
        "month": "12",
        "volume": "506",
        "pages": "110405",
        "link": "http://identifiers.org/pubmed/32738266",
        "authors": [
            {
                "name": "Salma M Al-Tuwairqi",
                "institution": "Mathematics department, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: saltuwairqi@kau.edu.sa.",
                "orcid": "0000-0001-5038-7950"
            },
            {
                "name": "Najwa O Al-Johani",
                "institution": "Mathematics department, King Abdulaziz University, Jeddah, Saudi Arabia."
            },
            {
                "name": "Eman A Simbawa",
                "institution": "Mathematics department, King Abdulaziz University, Jeddah, Saudi Arabia.",
                "orcid": "0000-0003-4831-1249"
            }
        ]
    },
    "files": {
        "main": [
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment.xml",
                "description": "SBML L2V4 representation of Al-Tuwairqi2020 - Phase II radiovirotherapy model",
                "fileSize": "36656",
                "mimeType": "application/xml",
                "md5sum": "25323850dbbebddb8d90948948611626",
                "sha1sum": "4c82b386a7f7ee7eaf0b3f118489f436d4afda02",
                "sha256sum": "fa6c7abf984b6ae124a49d5b68ed2870e0044f24e6ddea3cfb7241b85a78fba8"
            }
        ],
        "additional": [
            {
                "name": "Al-Tuwairqi2020 - Fig8 simulation.sedml",
                "description": "SED-ML file for the simulation of Figure 8 (additionally CRBM-validated and adjusted).",
                "fileSize": "13981",
                "mimeType": "application/xml",
                "md5sum": "7798224df3bdc7f5e5fd4b28e5b92c95",
                "sha1sum": "65bda124a672ba43217f6b6aa26440e472815822",
                "sha256sum": "0fe0d8187c2977ff1589c905df034512be47bdcc6068c6296209ba20ab458fea"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment-biopax2.owl",
                "description": "Auto-generated BioPAX (Level 2) file.",
                "fileSize": "17234",
                "mimeType": "application/rdf+xml",
                "md5sum": "426f4542980f496a8a31756fb0d695e3",
                "sha1sum": "055d5fb46b3000986742eab3ac5eb6e61b59075d",
                "sha256sum": "384cd52b0325025f59aa19625d8dd5733ccaa9b6cd018dda104a6d30cf8638fe"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment-biopax3.owl",
                "description": "Auto-generated BioPAX (Level 3) file.",
                "fileSize": "23618",
                "mimeType": "application/rdf+xml",
                "md5sum": "4f3e5efc98023fc5254d74211f2578cd",
                "sha1sum": "02e9b3be96f7c578d01dd15daa223d204f6c3675",
                "sha256sum": "29f0b1f7f3e069ee04605c1427e67f5e1230c11049e5b9d5404c2af308245490"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment-matlab.m",
                "description": "Auto-generated Matlab file.",
                "fileSize": "5536",
                "mimeType": "text/x-matlab",
                "md5sum": "0d9306f0b76e8ea0280f50546bddbbaf",
                "sha1sum": "cd043ed769172751b6eb17229916bb9979955eae",
                "sha256sum": "2273284a6640dedfcda8f2cef9638e324ad56c9c6b8288b61a84ba619d3cc7c6"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment-octave.m",
                "description": "Auto-generated Octave file.",
                "fileSize": "5536",
                "mimeType": "text/x-matlab",
                "md5sum": "c4bd274a1a1f98704f58934c1a209657",
                "sha1sum": "230ee0419924e7d9f45d51edd5aca651e76fc961",
                "sha256sum": "f4660180576744bd6b7c2fed5b6f8eefd9ee896246936f66f2600d12b8c57746"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment.cps",
                "description": "COPASI file for Al-Tuwairqi2020 - Phase II radiovirotherapy model and  Figure 8 simulation",
                "fileSize": "62504",
                "mimeType": "application/xml",
                "md5sum": "b48e9d4dd2bcff9c5e0b2b9be87c9a3e",
                "sha1sum": "5240446058ec985d8a540a36318602eefaeb69c9",
                "sha256sum": "2a9d0e2bfd5e9772d2c9f863b87fae3f66486cdd74a0fefc1b911c3595baa0f0"
            },
            {
                "name": "Al-Tuwairqi2020 - Phase II radiovirotherapy treatment.ode",
                "description": "Auto-generated ODE file for XPP.",
                "fileSize": "3426",
                "mimeType": "text/plain",
                "md5sum": "c23702a71f8541adfa5e694776cf5e54",
                "sha1sum": "53a0eaee2ea35a90793e7c9d5e85c431824b5d81",
                "sha256sum": "812ccf51c0127051211ca4dd87d80d5bd66beabae807fe6ad08fa8764ba45b93"
            },
            {
                "name": "curation_image.png",
                "description": "Reproduced figure(s) from original curation.",
                "fileSize": "13777",
                "mimeType": "image/png",
                "md5sum": "5ad91d1c783a927c1106ba11164a4896",
                "sha1sum": "1d9e69a2fc0f26a96d8782c79acd8ef8ae646cb2",
                "sha256sum": "1f38d898d5fdfe80c8d992234723813ddcdf24478c43f75065216bfac1e0f041"
            },
            {
                "name": "curation_notes.txt",
                "description": "Notes from original curation (describes curation_image).",
                "fileSize": "136",
                "mimeType": "text/plain",
                "md5sum": "6ca0b70aa11f97a2594867446575cabb",
                "sha1sum": "984319f2d2ba86653255a95f00e6f0fad4a2c038",
                "sha256sum": "2848c5d8d7a51c74a70fad12edbf0e2045bfbe3ec5d4bd74bc9d4a7a366203fa"
            },
            {
                "name": "manifest.xml",
                "description": "Auto-generated manifest file for OMEX archives.",
                "fileSize": "1735",
                "mimeType": "application/xml",
                "md5sum": "c956be6ef3ee80e6b4e26ce6422f088d",
                "sha1sum": "73f1d4bc2b1d4da87810e2c48180a9519503de71",
                "sha256sum": "46578e3d610f7cbe923148090008355d87e9d0d3d671b3bafec717fb522d4d94"
            },
            {
                "name": "metadata.rdf",
                "description": "Auto-generated annotation metadata file.",
                "fileSize": "3433",
                "mimeType": "application/rdf+xml",
                "md5sum": "981042c54a4d2c74565d5dcd17d086c6",
                "sha1sum": "3f4b0cdb608a8e4483cca58ec9bfd255c0a39d4c",
                "sha256sum": "ac76e8bd90a6d40f08043e96840e8b436836d6ab4c248bd5bc46fc35abb89b41"
            }
        ]
    },
    "history": {
        "revisions": [
            {
                "version": 2,
                "submitted": 1629189941,
                "submitter": "Rahuman S Malik-Sheriff",
                "comment": "Automatically added model identifier BIOMD0000001032"
            },
            {
                "version": 3,
                "submitted": 1724292244,
                "submitter": "Lucian Smith",
                "comment": "CRBM-sponsored manual and automated updates."
            }
        ]
    },
    "firstPublished": 1725282017,
    "submissionId": "MODEL2108170001",
    "publicationId": "BIOMD0000001032",
    "modellingApproach": {
        "accession": "MAMO_0000046",
        "name": "ordinary differential equation model",
        "resource": "http://identifiers.org/mamo/MAMO_0000046"
    },
    "curationStatus": "CURATED",
    "modelTags": [
        "Immuno-oncology"
    ],
    "contributors": {
        "Curator": [
            {
                "name": "Lucian Smith",
                "email": "lpsmith@uw.edu",
                "affiliation": "University of Washington",
                "orcid": "0000-0001-7002-6386",
                "external": false
            }
        ],
        "Modeller": [
            {
                "name": "Rahuman S Malik-Sheriff",
                "email": "sheriff@ebi.ac.uk",
                "affiliation": "European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.",
                "orcid": "0000-0003-0705-9809",
                "external": false
            }
        ]
    },
    "vcsIdentifier": "aaj",
    "modelLevelAnnotations": [
        {
            "qualifier": "bqbiol:hasTaxon",
            "accession": "9606",
            "name": "Homo sapiens",
            "resource": "Taxonomy",
            "uri": "http://identifiers.org/taxonomy/9606"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "DOID:162",
            "name": "cancer",
            "resource": "Human Disease Ontology",
            "uri": "http://identifiers.org/doid/DOID:162"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "MAMO_0000046",
            "name": "Ordinary differential equation model",
            "resource": "Mathematical Modelling Ontology",
            "uri": "http://identifiers.org/mamo/MAMO_0000046"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "GO:0002837",
            "name": "regulation of immune response to tumor cell",
            "resource": "Gene Ontology",
            "uri": "http://identifiers.org/go/GO:0002837"
        },
        {
            "qualifier": "bqbiol:isPropertyOf",
            "accession": "C15438",
            "name": "Cancer Immunotherapy",
            "resource": "NCIt",
            "uri": "http://identifiers.org/ncit/C15438"
        },
        {
            "qualifier": "bqmodel:isDescribedBy",
            "accession": "32738266",
            "resource": "PubMed",
            "uri": "https://identifiers.org/pubmed:32738266"
        },
        {
            "qualifier": "bqbiol:isPropertyOf",
            "accession": "C62713",
            "name": "Oncolytic Virus Therapy",
            "resource": "NCIt",
            "uri": "http://identifiers.org/ncit/C62713"
        },
        {
            "qualifier": "bqbiol:isDescribedBy",
            "accession": "32738266",
            "resource": "PubMed",
            "uri": "http://identifiers.org/pubmed/32738266"
        },
        {
            "qualifier": "bqmodel:is",
            "accession": "MODEL2108170001",
            "resource": "BioModels Database",
            "uri": "http://identifiers.org/biomodels.db/MODEL2108170001"
        },
        {
            "qualifier": "bqmodel:is",
            "accession": "BIOMD0000001032",
            "resource": "BioModels Database",
            "uri": "http://identifiers.org/biomodels.db/BIOMD0000001032"
        },
        {
            "qualifier": "bqbiol:isPropertyOf",
            "accession": "NCIT:C15313",
            "name": "Radiation Therapy",
            "resource": "NCIt",
            "uri": "http://identifiers.org/ncit/C15313"
        }
    ]
}